Omnia Wellness (OMWS) 10-Q 3 Dec 21 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Sep. 30, 2021	Nov. 30, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--03-31
Entity File Number	333-211986
Entity Registrant Name	OMNIA WELLNESS INC.
Entity Central Index Key	0001676852
Entity Tax Identification Number	98-1291924
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	999 18th Street
Entity Address, Address Line Two	Suite 3000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(888)
Local Phone Number	320-5711
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		224,227,107

Consolidated Balance Sheet (Una

Consolidated Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2021	Mar. 31, 2021
Assets
Cash	$ 67,326	$ 28,761
Lease receivable	66,950	38,341
Due from related parties	206,700	163,200
Advances on inventory	40,000	16,000
Total current assets	380,976	246,302
Non-current assets
Fixed assets, net	417,602	314,377
Intangible assets, net	1,500,925	1,600,975
Total non-current assets	1,918,527	1,915,352
Total Assets	2,299,503	2,161,654
Current liabilities:
Accounts payable and accrued expenses	112,477	103,205
Accrued interest	441,313	1,500
Accounts payable, related party	0	427,910
Deposit liability	21,454	21,764
Warranty liability	25,667	25,667
Convertible notes	5,710,512	4,401,358
Total current liabilities	6,311,423	4,981,404
Non-Current liabilities
PPP loan	148,625	588,891
Total non-current liabilities	148,625	588,891
Total liabilities	6,460,048	5,570,295
Stockholders’ deficit:
Common stock, par value $0.001; Authorized – 1,500,000,000; Issued and outstanding 224,227,107 on September 30, 2021, and 100,000,000 authorized and 14,900,629 issued and outstanding on March 31, 2021	14,900	14,900
Additional paid in capital benefit conversion feature on convertible notes	771,576
Additional paid-in capital	2,478,761	2,065,923
Accumulated deficit	(7,425,782)	(5,489,464)
Total stockholders’ deficit	(4,160,545)	(3,408,641)
Total Liabilities and Stockholders’ Deficit	$ 2,299,503	$ 2,161,654

Consolidated Balance Sheet (U_2

Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Mar. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	150,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,500,000,000	100,000,000
Common stock, shares outstanding	224,227,107	14,900,629
Common stock, shares issued	224,227,107	14,900,629

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Total Revenue	$ 57,809	$ 75,000	$ 94,931	$ 63,764
Total cost of goods sold	8,477	70,826	15,010	89,995
Gross profit	49,332	4,174	79,921	(26,231)
Operating expenses:
Legal and professional expense	255,048	133,904	356,002	213,294
Payroll expense	58,937	29,714	84,104	101,049
R&D Expense DryRx	397,500	0	732,000	0
Selling and marketing expense	30,544	152,896	30,920	163,138
Depreciation and amortization	72,557	69,913	143,036	138,777
General and administrative	9,184	90,250	68,412	225,744
Total operating expenses	823,770	476,677	1,414,474	842,002
Income (loss) from operations	(774,438)	(472,503)	(1,334,553)	(868,233)
Other expense:
Interest expense	147,231	378,419	274,062	364,915
Interest expense on beneficial conversion feature on convertible notes	771,576	0	771,576	0
Forgiveness of PPP Loan	146,959		443,873
Total other (expenses) Income	(771,848)	(378,419)	(601,765)	(364,915)
Net loss before income taxes	(1,546,286)	(850,922)	(1,936,318)	(1,233,148)
Income taxes
Net income (loss)	$ (1,546,286)	$ (850,922)	$ (1,936,318)	$ (1,233,148)

Statements of Changes in Stockh

Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2020	$ 55,058	$ (10,224)	$ (77,847)	$ (33,013)
Shares, Outstanding, Beginning Balance at Mar. 31, 2020	55,058,006
Net Income (Loss)			(275,957)	(275,957)
Balance at Jun. 30, 2020	$ 55,058	(10,224)	(353,804)	(308,970)
Shares, Outstanding, Ending Balance at Jun. 30, 2020	55,058,006
Balance at Mar. 31, 2020	$ 55,058	(10,224)	(77,847)	(33,013)
Shares, Outstanding, Beginning Balance at Mar. 31, 2020	55,058,006
Net Income (Loss)				(1,233,148)
Balance at Sep. 30, 2020	$ 14,900	(1,064,440)	(3,451,185)	(4,500,725)
Shares, Outstanding, Ending Balance at Sep. 30, 2020	14,900,629
Balance at Jun. 30, 2020	$ 55,058	(10,224)	(353,804)	(308,970)
Shares, Outstanding, Beginning Balance at Jun. 30, 2020	55,058,006
Additional paid in capital		(1,054,216)	(1,054,216)	(1,054,216)
Reverse Merger Adjustment			(1,546,047)	(1,546,047)
Net Income (Loss)			(850,922)	(850,922)
Balance at Sep. 30, 2020	$ 14,900	(1,064,440)	(3,451,185)	(4,500,725)
Shares, Outstanding, Ending Balance at Sep. 30, 2020	14,900,629
Balance at Mar. 31, 2021	$ 14,900	2,065,923	(5,489,464)	(3,408,641)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	14,900,629
Stock Split	209,326,478
Additional paid in capital		430,123		430,123
Net Income (Loss)			(390,032)	(390,032)
Balance at Jun. 30, 2021	$ 14,900	2,496,046	(5,879,496)	(3,368,550)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	224,227,107
Balance at Mar. 31, 2021	$ 14,900	2,065,923	(5,489,464)	(3,408,641)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	14,900,629
Net Income (Loss)				(1,936,318)
Balance at Sep. 30, 2021	$ 14,900	3,250,337	(7,425,782)	(4,160,545)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	224,227,107
Balance at Jun. 30, 2021	$ 14,900	2,496,046	(5,879,496)	(3,368,550)
Shares, Outstanding, Beginning Balance at Jun. 30, 2021	224,227,107
Additional paid in capital		754,291		754,291
Net Income (Loss)			(1,546,286)	(1,546,286)
Balance at Sep. 30, 2021	$ 14,900	$ 3,250,337	$ (7,425,782)	$ (4,160,545)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	224,227,107

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ (1,936,318)	$ (1,233,148)
Changes in net assets and liabilities
Accounts payable and accrued expenses	7,771	295,555
Depreciation and amortization	143,576	68,863
Inventory	(24,000)	0
Interest receivable		(4,884)
Accounts receivable	(72,418)	(58,800)
PPP loan	(440,266)	0
Note Receivable		1,050
Accrued interest	13,401	391,624
Interest expense on beneficial conversion feature on convertible notes	771,576	0
Cash used in operating activities:	(1,536,678)	(539,740)
Cash flows from investing activities:
Fixed assets, net	(146,750)	(578,979)
Intangible assets, net	0	(1,701,000)
Cash provided by investing activities	(146,750)	(2,279,979)
Cash flows from financing activities:
Proceeds from loan payable	1,309,154	5,937,780
Cash received from common stock	412,839	(3,234,564)
Cash provided by financing activities	1,721,993	2,703,216
Change in cash	38,565	(116,503)
Cash- beginning of period	28,761
Cash-end of period	$ 67,326	$ (116,503)

Nature of Operations

Nature of Operations	6 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Note 1 Nature of Operations Omnia Wellness Inc. (the “Company”) was incorporated as a Nevada corporation on March 2, 2016 Nevada On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 95.6 On March 5, 2020, the Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to, among other things, (i) increase the Company’s authorized shares of common stock from 75,000,000 100,000,000 10,000,000 12.6374:1 forward stock On April 17, 2020, the Company entered into a Share Exchange and Reorganization Agreement (the “Exchange Agreement”) with Omnia Wellness Corporation (formerly known as Bed Therapies Inc.), a Texas corporation (“Omnia Corp.”), and the beneficial stockholders of Omnia Corp. to acquire 100% 0.001 Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly owned subsidiary. 52,656,888 (pre-stock split) shares of the Company’s common stock owned beneficially and of record by him as part of the conditions to Closing, which were cancelled immediately following the Closing. The Company also issued an aggregate of 1,269,665 (pre-stock split) shares of common stock on January 5, 2021, as a result of the conversion in accordance with their terms of outstanding convertible promissory notes in the aggregate principal amount of approximately $ 539,000 . As of immediately prior to the closing of the Acquisition, the Company entered into an Assignment and Assumption Agreement with RZI Consulting LLC (the “Assignment Agreement”), pursuant to which RZI Consulting LLC assumed substantially all of the Company’s remaining assets and liabilities through the closing of the Acquisition. Accordingly, as of the closing of the Acquisition, the Company had no assets or liabilities (other than relating to general and administrative expenses). Following the Acquisition, the Company, through its wholly owned subsidiary Omnia Corp., now develops and markets products for wellness and physical therapy markets, using patented dry-hydro therapy equipment that the Company plans to offer and sell in medical and fitness markets. On April 6, 2021, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 1,500,000,000 10,000,000 150,000,000 The Company’s principal executive office is located at 999 18 th In March 2020 the World Health Organization declared COVID-19 a pandemic. The Company is still assessing the impact COVID-19 may have on its business, but there can be no assurance that this analysis will enable the Company to avoid part or all of any impact from the spread of COVID-19 or its consequences, including downturns in business sentiment generally. The extent to which the COVID-19 pandemic and global efforts to contain its spread will impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 Summary of Significant Accounting Policies The principal accounting policies applied in the preparation of these financial statements are set out below. Basis of Presentation Principles of Consolidation Accounting Estimates Risks and Uncertainties Loss Per Common Share - Basic net loss per common share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding for each period presented. Diluted net loss per common share is computed by giving effect to all potential shares of common stock, including stock options and warrants, to the extent dilutive. As of September 30, 2021, and 2020, there were 224,227,107 and 55,058,006 Cash Related Party Transactions Advance Payments on Purchases of Inventory, related party 40,000 0 Fixed Assets 60 169,230 97,276 Patent Cost 10 500,075 300,000 License Payable, related party Warranty Liability Beneficial Conversion Features Derivatives Revenue The Company derives its revenues primarily from the sale and revenue share of hydro therapy massage beds and installation services. Revenues are recognized when control of these products or services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products and services. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. The Company also derives revenue from equipment placed in use in which customers pay to use the equipment and revenue is recorded at the time the service is performed. The Company records leases of inventory under ASC 842 - Leases. Due to the probability of collection, the Company maintains the assets on the financials and records a deposit liability for the payments received until the collectability becomes probable. Once collectability becomes probable, the asset is derecognized, and the lease investment is recorded. The leases tend to have a fixed monthly payment, and some include a revenue share for additional revenues the equipment generates. The leases have a lease term of 48 to 60 months and the right of the lease to purchase the bed at the end of the lease term. Income Taxes The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carrybacks and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary. Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of September 30, 2021, and 2020 due to the relatively short maturity of the respective instruments. Recently Issued Accounting Pronouncements - Leases (Topic 842) Leases (Topic 842): Targeted Improvements Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments

Going Concern

Going Concern	6 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 Going Concern The Company adopted Accounting Standards Update No. 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”) The Company is commencing operations to generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Related Parties

Related Parties	6 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Parties	Note 4 Related Parties The Company outsources its manufacturing pursuant to a Contract Services Agreement with DryRX, LLC dated as of January 1, 2020, which replaced and superseded the Contract Services Agreement with DryRX, LLC dated as of July 22, 2018, which expired in accordance with its terms. The Contract Services Agreement, among other things, provides that DryRX shall provide manufacturing and support services on behalf of the Company, and shall be responsible for the manufacturing oversight and production operations of the Company’s products. In return, the Company is obligated to pay to DryRX a fee equal to 10 The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $ 15,000 April 30, 2020 68,262 111,884 1,500 1,500

Fixed Assets

Fixed Assets	6 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 5 Fixed Assets The carrying basis and accumulated depreciation of fixed assets at September 30, 2021 and 2020 is as follows: Schedule of Fixed Assets Useful Lives September 30, 2021 September 30, 2020 Inventory at 3 rd 5 $ 212,000 329,000 Equipment in use 5 $ 147,000 $ 0 Vehicles and Trailers 5 60,266 60,266 Research and Development 5 0 217,076 Patent Costs 10 2,001,000 0 Building improvements 40 167,565 0 Less depreciation and amortization 669,304 97,277 Total fixed assets, net $ 1,918,527 509,065 The Company recorded depreciation expense, including depreciation on equipment in use and leased equipment, of $ 61,700 57,340

License Agreement, Related Part

License Agreement, Related Party	6 Months Ended
	Sep. 30, 2021
License Agreement Related Party
License Agreement, Related Party	Note 6 License Agreement, Related Party On April 30, 2019, the Company entered worldwide exclusive license with Drywave Technologies, Inc. (“Drywave”), a Company owned by Steve Howe. On the terms and conditions of the agreement, the Company received intellectual property rights to manufacture, use, and offer for sale all the products related to the patents and trademarks for dry hydrotherapy therapy technologies. The license fee to acquire the technology was $ 2,000,000 (a) $ 350,000 1,000 (b) $ 200,000 (c) $ 1,450,000 The Company made all the required payments as of March 31, 2021. After payment of the $2,000,000 License Fee, the Company pays to Drywave a royalty of 3% of Net Sales for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement The company recorded the original license fee as an intangible asset as of April 30, 2019, and is amortizing the asset over the expected useful life of the asset of 10 50,025 50,000

Notes Payable

Notes Payable	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Notes Payable	Note 7 Notes Payable The following are the various notes payable of the Company: PPP Loan - 294,066 145,411 151,502 294,825 146,959 , Nonconvertible notes, related party - 1,244,655 1,180,937 63,718 Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity September 30, 2021 4.00 % 12/31/2018 12/31/2020 55,250 4.00 % 12/31/2018 12/31/2020 66,900 4.00 % 12/31/2018 12/31/2020 74,220 4.00 % 9/30/2019 9/29/2021 314,000 4.00 % 9/17/2019 9/16/2020 81,500 4.00 % 9/30/2019 9/29/2021 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2021 53,100 4.00 % 12/31/2020 12/31/2021 13,468 1,244,655 Nonconvertible notes, non-related- 2,670,844 2,468,219 202,625 Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity September 30, 2021 14.00 % 8/1/18 1/31/20 500,000 14.00 % Additional 2 % 10/30/19 10/29/20 229,500 14.00 % - 2/5/2020 2/5/2021 51,000 - % - % 2/28/2020 8/27/2020 372,219 20.00 % Additional 2 % 2/25/2020 8/24/2020 208,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 102,000 14.00 % Additional 2 % 12/31/2019 12/31/2020 102,000 20.00 % Additional 2 % 4/24/2020 4/23/2021 20,000 30.00 % Additional 2 % 10/29/2020 2/28/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 20.00 % - 2/5/2021 7/4/2021 112,000 18.20 % 25.00 % 9/18/2019 9/18/2023 25,055 18.20 % 25.00 % 10/9/2019 10/9/2023 40,100 18.20 % 24.00 % 3/10/2020 3/10/2024 94,420 15.00 % - 4/1/2021 3/31/2022 43,050 10.00 % - 4/1/2021 3/31/2022 100,000 12.00 % - 6/23/2021 6/22/2022 595,000 2,670,844 Convertible notes, related party 29,970 4 2 December 30, 2021 one-year period the notes will bear interest at an annual rate of eight percent Convertible notes, non related 1,811,643 in unsecured notes payable bearing average annual interest rates of 10 %. The notes are due between March – October 2022 unless sooner paid in full or converted in accordance with the terms of conversion; provided, however, that if a “Qualified IPO” does not occur on or before the maturity date, the maturity date shall be extended automatically for an additional one-year period the notes will bear interest at an annual rate of eight percent (10%) . The maturity date of these notes was extended to December 2021. Upon commencement by the Company of an underwritten initial public offering or the completed Share Exchange and Reorganization Agreement, of Borrower’s common stock, the Note principal, together with all accrued and unpaid interest, will be converted into Shares as of the date of such commencement. After the share exchange was completed, the Company negotiated with the lenders to convert the loans for securities of the Company determined by dividing the outstanding balance of the Note and accrued interest by $1.80, subject to adjustment. The Company evaluates these notes at commencement for beneficial conversion features and derivatives and concluded there were none. Auctus Loan 650,000 4,333,333 0.15

Shareholders_ Equity

Shareholders’ Equity	6 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Shareholders’ Equity	Note 8 Shareholders’ Equity Common Stock - 1,500,000,000 0.001 a. One non-cumulative vote for each share held of record on all matters submitted to a vote of the stockholders; b. To participate equally and to receive all such dividends as may be declared by the Board of Directors out of funds legally available; therefore, and c. To participate pro rata in any distribution of assets available for distribution upon liquidation. Stockholders have no pre-emptive rights to acquire additional shares of common stock or any other securities. Common shares are not subject to redemption and carry no subscription or conversion rights. Preferred Stock 10,000,000 150,000,000 No The Company has not declared or paid any dividends or returned any capital to common stock shareholders as of September 30, 2021, and 2020.

Income Taxes

Income Taxes	6 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Note 9 Income Taxes Income Tax Expense For the fiscal year ended September 31, 2021, the reconciliation between the income tax benefit computed by applying the statutory U.S. federal income tax rate to the pre-tax loss before income taxes, and total income tax expense recognized in the financial statements is the change in the valuation allowance. For the fiscal year ended September 31, 2021, and 2020, the Company did no NOL Carryforwards and Other Matters The Company files income tax returns in the U.S. federal jurisdiction and the state of Colorado. The Company’s federal and state tax years for the 2018 fiscal year and forward are subject to examination by taxing authorities. The Company did no

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10 Commitments and Contingencies Off-Balance Sheet Arrangements - Leases - 200 The Company leases a warehouse facility of approximately 1,500 Licenses 2 Legal Matters

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11 Subsequent Events On July 20, 2021, the principal balance under the Auctus Note was increased by $ 25,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation
Accounting Estimates	Accounting Estimates
Risks and Uncertainties	Risks and Uncertainties
Loss Per Common Share	Loss Per Common Share - Basic net loss per common share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding for each period presented. Diluted net loss per common share is computed by giving effect to all potential shares of common stock, including stock options and warrants, to the extent dilutive. As of September 30, 2021, and 2020, there were 224,227,107 and 55,058,006
Cash	Cash
Related Party Transactions	Related Party Transactions
Advance Payments on Purchases of Inventory, related party	Advance Payments on Purchases of Inventory, related party 40,000 0
Fixed Assets	Fixed Assets 60 169,230 97,276
Patent Cost	Patent Cost 10 500,075 300,000
License Payable, related party	License Payable, related party
Warranty Liability	Warranty Liability
Beneficial Conversion Features	Beneficial Conversion Features
Derivatives	Derivatives
Revenue	Revenue The Company derives its revenues primarily from the sale and revenue share of hydro therapy massage beds and installation services. Revenues are recognized when control of these products or services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products and services. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. The Company also derives revenue from equipment placed in use in which customers pay to use the equipment and revenue is recorded at the time the service is performed. The Company records leases of inventory under ASC 842 - Leases. Due to the probability of collection, the Company maintains the assets on the financials and records a deposit liability for the payments received until the collectability becomes probable. Once collectability becomes probable, the asset is derecognized, and the lease investment is recorded. The leases tend to have a fixed monthly payment, and some include a revenue share for additional revenues the equipment generates. The leases have a lease term of 48 to 60 months and the right of the lease to purchase the bed at the end of the lease term.
Income Taxes	Income Taxes The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carrybacks and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warrant liability and notes payable approximated fair value as of September 30, 2021, and 2020 due to the relatively short maturity of the respective instruments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements - Leases (Topic 842) Leases (Topic 842): Targeted Improvements Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments

Fixed Assets (Tables)

Fixed Assets (Tables)	6 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	The carrying basis and accumulated depreciation of fixed assets at September 30, 2021 and 2020 is as follows: Schedule of Fixed Assets Useful Lives September 30, 2021 September 30, 2020 Inventory at 3 rd 5 $ 212,000 329,000 Equipment in use 5 $ 147,000 $ 0 Vehicles and Trailers 5 60,266 60,266 Research and Development 5 0 217,076 Patent Costs 10 2,001,000 0 Building improvements 40 167,565 0 Less depreciation and amortization 669,304 97,277 Total fixed assets, net $ 1,918,527 509,065

Notes Payable (Tables)

Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of Nonconvertible Notes Related Party	Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity September 30, 2021 4.00 % 12/31/2018 12/31/2020 55,250 4.00 % 12/31/2018 12/31/2020 66,900 4.00 % 12/31/2018 12/31/2020 74,220 4.00 % 9/30/2019 9/29/2021 314,000 4.00 % 9/17/2019 9/16/2020 81,500 4.00 % 9/30/2019 9/29/2021 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2021 53,100 4.00 % 12/31/2020 12/31/2021 13,468 1,244,655
Schedule of Nonconvertible Notes Non Related	Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity September 30, 2021 14.00 % 8/1/18 1/31/20 500,000 14.00 % Additional 2 % 10/30/19 10/29/20 229,500 14.00 % - 2/5/2020 2/5/2021 51,000 - % - % 2/28/2020 8/27/2020 372,219 20.00 % Additional 2 % 2/25/2020 8/24/2020 208,000 20.00 % Additional 2 % 2/28/2020 8/27/2020 102,000 14.00 % Additional 2 % 12/31/2019 12/31/2020 102,000 20.00 % Additional 2 % 4/24/2020 4/23/2021 20,000 30.00 % Additional 2 % 10/29/2020 2/28/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 12.00 % Additional 2 % 10/30/2020 11/1/2021 25,500 20.00 % - 2/5/2021 7/4/2021 112,000 18.20 % 25.00 % 9/18/2019 9/18/2023 25,055 18.20 % 25.00 % 10/9/2019 10/9/2023 40,100 18.20 % 24.00 % 3/10/2020 3/10/2024 94,420 15.00 % - 4/1/2021 3/31/2022 43,050 10.00 % - 4/1/2021 3/31/2022 100,000 12.00 % - 6/23/2021 6/22/2022 595,000 2,670,844

Nature of Operations (Details N

Nature of Operations (Details Narrative) - USD ($)	Apr. 06, 2021	Apr. 06, 2021	Jan. 05, 2021	Apr. 17, 2020	Mar. 05, 2020	Jun. 25, 2019	Sep. 30, 2021	Mar. 31, 2021	Mar. 04, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Entity incorporation, date of incorporation							Mar. 2, 2016
Entity Incorporation, State or Country Code							NV
Equity method investment description							On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 shares (pre- stock split) of the Company’s common stock, sold all his shares of common stock of the Company to Amer Samad, resulting in a change of control of the Company. As part of that transaction, Mr. Charniak resigned from all of his officer and director positions, and Mr. Samad was appointed as the Chief Executive Officer, President, Chief Financial Officer and Secretary of the Company, and was appointed to the Board of Directors of the Company. Mr. Samad also purchased 1,167,937 shares (pre-stock split) of the Company’s common stock in a series of private transactions, resulting in Mr. Samad owning 4,167,937 shares (pre-stock split) of the Company’s common stock, or approximately 95.6% of the issued and outstanding common stock of the Company.
Common stock, shares authorized					100,000,000		1,500,000,000	100,000,000	75,000,000
Preferred stock authorized							150,000,000	10,000,000
Forward stock split					12.6374:1 forward stock
Common stock, par value							$ 0.001	$ 0.001
Minimum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, shares authorized	100,000,000	100,000,000
Preferred stock authorized	10,000,000	10,000,000
Maximum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, shares authorized	1,500,000,000	1,500,000,000
Preferred stock authorized	150,000,000	150,000,000
Exchange Agreement [Member] | Bed Therapies Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares pre stock splits issued			1,269,665
Ownership percentage				100.00%
Forward stock split		Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly owned subsidiary.
Common stock, par value				$ 0.001
Debt Conversion, Converted Instrument, Amount				$ 539,000
Blank Check [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Preferred stock authorized					10,000,000
Mr. Amer Samad [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares pre stock splits issued						3,000,000
Ownership percentage						95.60%
Mr. Amer Samad [Member] | Exchange Agreement [Member] | Bed Therapies Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Forward stock split	Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 to 1,500,000,000, (ii) increase the Company’s authorized shares of “blank check” preferred stock from 10,000,000 to 150,000,000, and (iii) effect a 1:15 forward stock split of the common stock.
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation				52,656,888

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Apr. 30, 2019	Sep. 30, 2021	Sep. 30, 2020
Accounting Policies [Abstract]
Number of anti-dilutive common stock		224,227,107	55,058,006
Advances on inventory		$ 40,000	$ 0
Fixed asset useful lives		60 months
Accumulated depreciation		$ 169,230	97,276
Intangible asset expected life	10 years	10 years
Accumulated amortization		$ 500,075	$ 300,000
Income Tax Examination, Likelihood of Unfavorable Settlement		The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Related Parties (Details Narrat

Related Parties (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Related Party Transaction [Line Items]
Net sales percentage	10.00%
Related party transaction, description	The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $15,000 per month. The agreement expired on April 30, 2020, with renewal options. The Company incurred consulting expense, related party of $68,262 and $111,884 as of September 30, 2021, and 2020, respectively. The Company also has an accounts payable, related party balance of $1,500 and $1,500 as of September 30, 2021, and 2020, respectively. The due to and due from accounts are to various investors and related parties above for business related activities.
Agreement expires date	Apr. 30, 2020
Consulting expense, related party	$ 68,262	$ 111,884
Accounts payable, related party	1,500	$ 1,500
Massagewave Inc [Member]
Related Party Transaction [Line Items]
Payments of related party	$ 15,000

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Line Items]
Useful Lives	60 months
Less depreciation and amortization	$ 669,304	$ 97,277
Total fixed assets, net	$ 1,918,527	509,065
Inventory [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	5 years
Property, Plant and Equipment, Gross	$ 212,000	329,000
Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	5 years
Property, Plant and Equipment, Gross	$ 147,000	0
Vehicles and Trailers [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	5 years
Property, Plant and Equipment, Gross	$ 60,266	60,266
Research and Development [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	5 years
Property, Plant and Equipment, Gross	$ 0	217,076
Patent Costs [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	10 years
Property, Plant and Equipment, Gross	$ 2,001,000	0
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful Lives	40 years
Property, Plant and Equipment, Gross	$ 167,565	$ 0

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Equipment in Use and Leased Equipment [Member]
Property, Plant and Equipment [Line Items]
Depreciation	$ 61,700	$ 57,340

License Agreement, Related Pa_2

License Agreement, Related Party (Details Narrative) - USD ($)	Mar. 02, 2020	Oct. 30, 2019	Apr. 30, 2019	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2021	Aug. 30, 2019
Defined Benefit Plan Disclosure [Line Items]
Payment to acquire technology	$ 1,450,000	$ 200,000	$ 350,000
Payment of escrow fee			$ 1,000
Related Party Transaction, Description of Transaction				The Company entered into a Consulting Agreement with Massagewave, Inc, owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $15,000 per month. The agreement expired on April 30, 2020, with renewal options. The Company incurred consulting expense, related party of $68,262 and $111,884 as of September 30, 2021, and 2020, respectively. The Company also has an accounts payable, related party balance of $1,500 and $1,500 as of September 30, 2021, and 2020, respectively. The due to and due from accounts are to various investors and related parties above for business related activities.
Intangible asset expected life			10 years	10 years
License Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization expense				$ 50,025	$ 50,000
Drywave Technologies Inc [Member] | License Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Accounts Payable, Related Parties							$ 2,000,000
Related Party Transaction, Description of Transaction						After payment of the $2,000,000 License Fee, the Company pays to Drywave a royalty of 3% of Net Sales for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement

Schedule of Nonconvertible Note

Schedule of Nonconvertible Notes Related Party (Details)	6 Months Ended
	Sep. 30, 2021USD ($)
Nonconvertible Notes Related Party One [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 55,250
Nonconvertible Notes Related Party Two [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 66,900
Nonconvertible Notes Related Party Three [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 74,220
Nonconvertible Notes Related Party Four [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2021
Unsecured Notes Payable	$ 314,000
Nonconvertible Notes Related Party Five [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 17, 2019
Maturity	Sep. 16, 2020
Unsecured Notes Payable	$ 81,500
Nonconvertible Notes Related Party Six [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2021
Unsecured Notes Payable	$ 12,450
Nonconvertible Notes Related Party Seven [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 254,382
Nonconvertible Notes Related Party Eight [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 235,600
Nonconvertible Notes Related Party Nine [Member]
Short-term Debt [Line Items]
Interest Rate	1.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Notes Payable	$ 83,785
Nonconvertible Notes Related Party Ten [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 53,100
Nonconvertible Notes Related Party Eleven [Member]
Short-term Debt [Line Items]
Interest Rate	4.00%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 13,468
Nonconvertible Notes Related Party [Member]
Short-term Debt [Line Items]
Unsecured Notes Payable	$ 1,244,655

Schedule of Nonconvertible No_2

Schedule of Nonconvertible Notes Non Related (Details)	6 Months Ended
	Sep. 30, 2021USD ($)
Nonconvertible Notes Non Related One [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Aug. 1, 2018
Maturity	Jan. 31, 2020
Unsecured Notes Payable	$ 500,000
Nonconvertible Notes Non Related Two [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Oct. 30, 2019
Maturity	Oct. 29, 2020
Unsecured Notes Payable	$ 229,500
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Three [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Feb. 5, 2020
Maturity	Feb. 5, 2021
Unsecured Notes Payable	$ 51,000
Nonconvertible Notes Non Related Four [Member]
Short-term Debt [Line Items]
Issuance Date	Feb. 28, 2020
Maturity	Aug. 27, 2020
Unsecured Notes Payable	$ 372,219
Nonconvertible Notes Non Related Five [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 25, 2020
Maturity	Aug. 24, 2020
Unsecured Notes Payable	$ 208,000
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Six [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 28, 2020
Maturity	Aug. 27, 2020
Unsecured Notes Payable	$ 102,000
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Seven [Member]
Short-term Debt [Line Items]
Interest Rate	14.00%
Issuance Date	Dec. 31, 2019
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 102,000
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Eight [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Apr. 24, 2020
Maturity	Apr. 23, 2021
Unsecured Notes Payable	$ 20,000
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Nine [Member]
Short-term Debt [Line Items]
Interest Rate	30.00%
Issuance Date	Oct. 29, 2020
Maturity	Feb. 28, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Ten [Member]
Short-term Debt [Line Items]
Interest Rate	12.00%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 1, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Eleven [Member]
Short-term Debt [Line Items]
Interest Rate	12.00%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 1, 2021
Unsecured Notes Payable	$ 25,500
Debt instrument, default rate	2.00%
Nonconvertible Notes Non Related Twelve [Member]
Short-term Debt [Line Items]
Interest Rate	20.00%
Issuance Date	Feb. 5, 2021
Maturity	Jul. 4, 2021
Unsecured Notes Payable	$ 112,000
Nonconvertible Notes Non Related Thirteen [Member]
Short-term Debt [Line Items]
Interest Rate	18.20%
Issuance Date	Sep. 18, 2019
Maturity	Sep. 18, 2023
Unsecured Notes Payable	$ 25,055
Debt instrument, default rate	25.00%
Nonconvertible Notes Non Related Fourteen [Member]
Short-term Debt [Line Items]
Interest Rate	18.20%
Issuance Date	Oct. 9, 2019
Maturity	Oct. 9, 2023
Unsecured Notes Payable	$ 40,100
Debt instrument, default rate	25.00%
Nonconvertible Notes Non Related Fifteen [Member]
Short-term Debt [Line Items]
Interest Rate	18.20%
Issuance Date	Mar. 10, 2020
Maturity	Mar. 10, 2024
Unsecured Notes Payable	$ 94,420
Debt instrument, default rate	24.00%
Nonconvertible Notes Non Related Sixteen [Member]
Short-term Debt [Line Items]
Interest Rate	15.00%
Issuance Date	Apr. 1, 2021
Maturity	Mar. 31, 2022
Unsecured Notes Payable	$ 43,050
Nonconvertible Notes Non Related Seventeen [Member]
Short-term Debt [Line Items]
Interest Rate	10.00%
Issuance Date	Apr. 1, 2021
Maturity	Mar. 31, 2022
Unsecured Notes Payable	$ 100,000
Nonconvertible Notes Non Related Eighteen [Member]
Short-term Debt [Line Items]
Interest Rate	12.00%
Issuance Date	Jun. 23, 2021
Maturity	Jun. 22, 2022
Unsecured Notes Payable	$ 595,000
Nonconvertible Notes Non Related [Member]
Short-term Debt [Line Items]
Unsecured Notes Payable	$ 2,670,844

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Jun. 24, 2021	May 12, 2021	May 04, 2021	Feb. 28, 2021	Sep. 30, 2021	Mar. 31, 2021	Aug. 17, 2021	Jul. 20, 2021
Short-term Debt [Line Items]
Paycheck Protection Program Including Interest							$ 146,959
Auctus Fund LLC [Member]
Short-term Debt [Line Items]
Debt instrument principal amount								$ 25,000
Securities Purchase Agreement [Member] | Auctus Fund LLC [Member]
Short-term Debt [Line Items]
Debt instrument principal amount	$ 650,000
Securities Purchase Agreement [Member] | Auctus Fund LLC [Member] | Warrant [Member]
Short-term Debt [Line Items]
Shares issued	4,333,333
Warrants exercise price	$ 0.15
Paycheck Protection Program [Member]
Short-term Debt [Line Items]
Proceeds from loan				$ 294,825
Paycheck Protection Program Loan [Member] | CARES Act [Member]
Short-term Debt [Line Items]
Proceeds from loan						$ 294,066
Debt instrument, forgiveness		$ 151,502	$ 145,411
Nonconvertible Notes Related Party [Member]
Short-term Debt [Line Items]
Unsecured notes payable					$ 1,244,655
Nonconvertible Notes Related Party [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable					1,244,655
Unsecured Debt, Current					1,180,937
Unsecured Long-term Debt, Noncurrent					63,718
Nonconvertible Notes Non Related [Member]
Short-term Debt [Line Items]
Unsecured notes payable					2,670,844
Nonconvertible Notes Non Related [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable					2,670,844
Unsecured Debt, Current					2,468,219
Unsecured Long-term Debt, Noncurrent					202,625
Convertible Notes Related Party [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable					$ 29,970
Debt instrument, interest rate					4.00%
Default interest rate					2.00%
Debt Instrument, Maturity Date					Dec. 30, 2021
Debt instrument, description					one-year period
Debt instrument, interest rate terms					the notes will bear interest at an annual rate of eight percent
Convertible Notes Non Related [Member] | Investor [Member]
Short-term Debt [Line Items]
Unsecured notes payable					$ 1,811,643
Debt instrument, interest rate					10.00%
Debt instrument, description					one-year period
Debt instrument, interest rate terms					the notes will bear interest at an annual rate of eight percent (10%)

Shareholders_ Equity (Details N

Shareholders’ Equity (Details Narrative) - $ / shares	Sep. 30, 2021	Apr. 06, 2021	Mar. 31, 2021	Mar. 05, 2020	Mar. 04, 2020
Common stock, shares authorized	1,500,000,000		100,000,000	100,000,000	75,000,000
Common stock par value	$ 0.001		$ 0.001
Preferred stock, shares authorized	150,000,000		10,000,000
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Minimum [Member]
Common stock, shares authorized		100,000,000
Preferred stock, shares authorized		10,000,000
Maximum [Member]
Common stock, shares authorized		1,500,000,000
Preferred stock, shares authorized		150,000,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income tax expense benefit	$ 0	$ 0
Unrecognized tax benefits	$ 0	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	6 Months Ended
	Sep. 30, 2021ft²
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Area of Land	200
Master Facility License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Area of Land	1,500
Gross revenue percentage	2.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Jul. 20, 2021USD ($)
Auctus Fund LLC [Member]
Increase in debt instrument, face amount	$ 25,000